CEFAZOLIN SODIUM (CEFAZOLIN SODIUM) — FDA Approval ANDA064033 (GLAXOSMITHKLINE)
CEFAZOLIN SODIUM (CEFAZOLIN SODIUM) — FDA Approval ANDA064033 (GLAXOSMITHKLINE) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CEFAZOLIN SODIUM; Active ingredients: CEFAZOLIN SODIUM; Application number: ANDA064033.
| Brand name | CEFAZOLIN SODIUM |
|---|---|
| Active ingredients | CEFAZOLIN SODIUM |
| Application number | ANDA064033 |
| Sponsor | GLAXOSMITHKLINE |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19931031 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →